A non-interventional, prospective study with benralizumab - AIR POWER

Study identifier:D3250R00124

ClinicalTrials.gov identifier:NCT06422078

EudraCT identifier:N/A

CTIS identifier:N/A

Recruiting

Official Title

A non-interventional, prospective study with benralizumab to investigate clinical outcome based on standard of care medication in real-life

Medical condition

ASTHMA, BRONCHIAL

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Estimated Enrollment

300

Study type

Observational

Age

18 Years - 120 Years

Date

Study Start Date: 25 Jul 2024
Estimated Primary Completion Date: 30 Jun 2026
Estimated Study Completion Date: 30 Jun 2026

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Sept 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

None

Inclusion and exclusion criteria